Mean Cost Per Number Needed to Treat of Baricitinib Versus Adalimumab in the Treatment of Rheumatoid Arthritis in Italy
Global and Regional Health Technology Assessment - Italy
doi 10.1177/2284240318790951
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2018
Authors
Publisher
Aboutscience Srl